Unique Research · Company / Data Digest · September 4, 2024 · Source: Crunchbase China & Asia Q2 2024 review (translator note: Crunchbase, founded 2007 by J. Michael Arrington of TechCrunch fame — major global startup/investor database)
Near-decade lows
Crunchbase: China startup funding in Q2 2024 fell to $7.4B, −42% from Q1’s $12.8B — lowest since Q3 2014. Path points to the weakest VC year since 2014 (~$20B+ that year). Asia-wide: startups raised only $14.6B in Q2 (−24% QoQ, −32% YoY) — steepest regional drop since Q4 2015. Deal count: 1,511 (−15% QoQ, −27% YoY).
Early-stage collapse
Biggest bruise: early-stage dollars at $2.5B in Q2 — near a 10-year floor, −67% from Q1’s $7.6B, and lowest since Q2 2014. Thin early capital caps growth into large rounds later — and eventually hits fund flows and returns.
Large growth rounds cooler
Late-stage + technology-growth totaled $3.9B (−13% YoY) — far below Q3’s $10B and Q4’s $7.8B last year. Q2 notables: EV Hozon (合众) $690M; manufacturing/AI MiniMax $600M B; semiconductor Unisoc ~$552M. Still smaller than Q1 giants: CXMT ~$1.5B (Mar), EV Zhiji $1.1B B (Mar), Moonshot AI $1B+ led by Alibaba + Sequoia China (Feb).
AI is not a full savior
U.S. markets lean on AI; China AI did not boom across the board. After a Q1 peak of $2.4B (Moonshot-driven), AI funding eased to $1.5B in Q2 with flattening momentum. China sets Asia’s tone — a prolonged VC slump can slow regional innovation. Crunchbase: maybe a blip — but founders and VCs must plan if it isn’t.
Methodology notes (Crunchbase)
Early seed figures lag and often revise up after quarter/year end. Amounts in USD at spot FX on event day (historical spot if logged late). From Jan 2023: corporate rounds counted only when equity via VC-series at seed. Seed/angel includes pre-seed/angel, unknown-series VC, equity crowdfunding, and convertibles ≤$3M. Early = A/B (+ unknown-series / CVC / other >$3M and ≤$15M). Late = C+ lettered (+ unknown/CVC/other >$15M). Technology growth = PE into companies that already raised “venture” rounds.
Charts (7) in CN package — attach on ingest.
— END —